Purdue Cancer Drug Platform (image)

Purdue University

Caption

Herman O. Sintim, the Drug Discovery Professor of Chemistry in Purdue's Department of Chemistry, is a co-founder and chief scientific officer of KinaRx. A $1,999,998 SBIR Phase I/II grant from the National Institute of Cancer to KinaRx LLC, a Purdue University-affiliated startup, will help fast-track to human trials a novel platform aimed at treating relapse for certain diseases.

Credit

Herman O. Sintim/Purdue University

Usage Restrictions

None

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.